| Activity |
| Catalytic type | Cysteine |
| Peplist | Included in the Peplist with identifier PL00063 |
| NC-IUBMB | Subclass 3.4 (Peptidases) >> Sub-subclass 3.4.22 (Cysteine endopeptidases) >> Peptidase 3.4.22.38
|
| Enzymology | BRENDA database |
| Proteolytic events | CutDB database (11 cleavages) |
| Activity status | human: active (Bromme, 2004) mouse: active (Lecaille et al., 2003)
|
| Physiology | Degrades the organic matrix of bone in osteoclastic bone resorption. |
| Knockout | Hereditary deficiency in human patients leads to pycnodysostosis, a rare, autosomal recessive skeletal dysplasia characterized by short stature, wide cranial sutures, and increased bone density and fragility (Gelb et al., 1996; Johnson et al., 1996; Hou et al., 1999). In cathepsin K-deficient mice, impaired osteoclastic bone resorption leads to osteopetrosis (Saftig et al., 1998). |
| Pharmaceutical relevance | Potential drug target for control of osteoporosis (Troen, 2004) and perhaps emphysema. |
| Pathways |
KEGG | Lysosome |
|
KEGG | Osteoclast differentiation |
|
KEGG | Rheumatoid arthritis |
|
KEGG | Toll-like receptor signaling pathway |
|
Other databases
| WIKIPEDIA | http://en.wikipedia.org/wiki/Cathepsin_K |
| Cleavage site specificity |
Explanations of how to interpret the
following cleavage site sequence logo and specificity matrix can be found here. |
| Cleavage pattern | -/-/l/- -/-/-/- (based on 10608 cleavages) |